[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-13387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates:
8:00 a.m.-6:00 p.m., June 25, 2014.
8:00 a.m.-1:30 p.m., June 26, 2014.
Place: Centers for Disease Control and Prevention, Tom Harkin
Global Communications Center, 1600 Clifton Road NE., Building 19,
Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate use of immunizing agents. In addition, under
42 U.S.C. Sec. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines. Further, under provisions of the Affordable Care Act,
at section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been adopted by the Director
of the Centers for Disease Control and Prevention must be covered by
applicable health plans.
Matters for Discussion: The agenda will include discussions on:
Yellow fever vaccine, human papillomavirus vaccines, influenza,
pneumococcal conjugate vaccine, tetanus, diphtheria, and acellular
pertussis vaccine in healthcare personnel, meningococcal vaccines,
child/adolescent immunization, adult immunization, immunization
safety, measles, hepatitis vaccines and vaccine supply.
Recommendation votes are scheduled for yellow fever vaccine and
influenza. Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836;
Email [email protected].
Meeting is webcast live via the World Wide Web; for instructions
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/acip/index.html.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-13387 Filed 6-6-14; 8:45 am]
BILLING CODE 4160-18-P